[1] Brinkmann V, Reichard U, Goosmann C, et al. Neutrophil extracellular traps kill bacteria[J]. Science, 2004, 303(5663):1532-1535.
[2] Papayannopoulos V. Neutrophil extracellular traps in immunity and disease[J]. Nat Rev Immunol, 2018, 18(2):134-147.
[3] Jorch SK, Kubes P. An emerging role for neutrophil extracellular traps in noninfectious disease[J]. Nat Med, 2017, 23(3):279-287.
[4] 谢雅清,梁晓美,叶伟霞. 还原型谷胱甘肽的药理作用与临床应用研究进展[J]. 中国药业, 2013, 22(7):124-127.
[5] 张北平,刘树锋,王海,等. GSH对于系统性红斑狼疮治疗观察[J]. 中国现代药物应用, 2016, 10(13):189-190.
[6] 张均,赵景宏,刘力,等. 还原型谷胱甘肽辅助治疗对狼疮肾炎患者肾小球系膜细胞CXCL9/10/11表达的影响[J]. 中国医学前沿杂志(电子版), 2017, 9(11):118-121.
[7] Domingo-Gonzalez R, Martinez-Colon G J, Smith A J, et al. Inhibition of neutrophil extracellular trap formation after stem cell transplant by prostaglandin E2[J]. Am J Respir Crit Care Med, 2016, 193(2):186-197.
[8] Lood C, Blanco LP, Purmalek MM, et al. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease[J]. Nat Med, 2016, 22(2):146-153.
[9] Hakkim A, Furnrohr BG, Amann K, et al. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis[J]. Proc Natl Acad Sci U S A, 2010,107(21):9813-9818.
[10] Knight JS, Subramanian V, O'Dell AA, et al. Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice[J]. Ann Rheum Dis, 2015, 74(12):2199-2206.
[11] Knight JS, Zhao W, Luo W, et al. Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus[J]. J Clin Invest, 2013, 123(7):2981-2993. |